US › Healthcare

Zai Lab Ltd (ZLAB)

US · Healthcare · Biotechnology

$18.49+1.71%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$99.6M
Revenue YoY
-6.5%
Net profit
$-51.0M
Profit YoY
-5.3%
EPS
$-0.46
EPS estimate
$-0.29
Net margin
-51.2%

EPS came in at -0.46 against a street estimate of -0.29 — a miss of 58.1%.

Key statistics

Market cap
$2.05B
Forward P/E
0.0
P/B
3.12
Book value
$5.96
EPS (TTM)
$-1.69
52-week high
$39.32
52-week low
$15.96
50-day MA
$18.62
200-day MA
$19.94
Beta
0.78

Analyst view

Analysts rate Zai Lab Ltd a strong buy (11 buy, 1 hold, 0 sell out of 12) with an average price target of $33.30.

Shareholding

Insiders
2.16%
Institutions
31.33%

Largest institutional holders

FundStake
RTW INVESTMENTS, LLC5.82%
RA Capital Management, LLC5.05%
Frazier Life Sciences Management, L.P.1.68%
Citadel Advisors Llc1.50%
BAMCO Inc1.47%
ADAR1 Capital Management LLC1.26%
FMR Inc1.12%
BlackRock Inc0.77%

Recent filings & reports

DocumentDate
Shareholder vote results · Q2 20262026-06-17
Board / officer change · Q2 20262026-05-21
Quarterly report · Q1 20262026-05-07
Results announced · Q2 20262026-05-07
Proxy statement · Q2 20262026-04-28
Annual report FY20252026-02-26
Results announced · Q1 20262026-02-26
Quarterly report · Q3 20252025-11-06

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Zai Lab Ltd — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.